carboplatin,durvalumab,gemcitabine,paclitaxel,vinorelbine,cisplatin,nivolumab,docetaxel,pemetrexed,ipilimumab,pembrolizumab
astrazeneca,merck,bms
['cm816', 'keynote,671', 'keynote 671']
the #oncoalerttoptweet day 2 #asco23
tweet great discussion of keynote 671 by dr. at #asco23. notes challenges of comparing studies given differences in populations. but efs curves do appear to widen over time and plateau - perhaps more than cm816. 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨